or Try an Advanced Search...

    Technical Analysis for AVTX - Avalo Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 10.90 -1.36% -0.15
    AVTX closed down 1.36 percent on Wednesday, November 20, 2024, on 1.37 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical AVTX trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    200 DMA Support Bullish 0.00%
    Hammer Candlestick Bullish 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Support Bullish -1.36%
    Stochastic Reached Oversold Weakness -1.36%
    Below Lower BB Weakness -1.36%
    Older End-of-Day Signals for AVTX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    1.5x Volume Pace about 21 hours ago
    200 DMA Support about 21 hours ago
    60 Minute Opening Range Breakdown about 22 hours ago
    Down 5% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AVTX Chart by TradingView
    Basic chart:

    Profile

    Avalo Therapeutics is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. The company has built a diverse portfolio of innovative therapies to deliver meaningful medical impact for patients in urgent need. The company’s clinical candidates commonly have a proven mechanistic rationale, biomarkers and/or an established proof-of-concept to expedite and increase the probability of success.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases

    Is AVTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Avalo Therapeutics receives $69.4M in proceeds from full exercise of private placement warrants
    Nov 12 Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
    Nov 11 Avalo Therapeutics to Present at Upcoming Investor Conferences
    Nov 7 Avalo Therapeutics GAAP EPS of -$2.83, revenue of $0.25M
    Nov 7 Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
    Oct 8 Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
    Sep 4 Avalo Announces Participation in September Investor Conferences
    Aug 12 Avalo Therapeutics GAAP EPS of -$14.07
    Aug 12 Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
    Jul 16 Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
    See more AVTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 34.46
    52 Week Low 3.9501
    Average Volume 36,008
    200-Day Moving Average 10.48
    50-Day Moving Average 11.05
    20-Day Moving Average 12.96
    10-Day Moving Average 12.50
    Average True Range 1.02
    RSI (14) 40.12
    ADX 30.77
    +DI 15.31
    -DI 23.64
    Chandelier Exit (Long, 3 ATRs) 12.95
    Chandelier Exit (Short, 3 ATRs) 13.38
    Upper Bollinger Bands 14.75
    Lower Bollinger Band 11.18
    Percent B (%b) -0.08
    BandWidth 27.49
    MACD Line 0.14
    MACD Signal Line 0.54
    MACD Histogram -0.3972
    Fundamentals Value
    Market Cap 8.74 Million
    Num Shares 802 Thousand
    EPS -480.00
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 1.67
    Price-to-Book 0.25
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.12
    Resistance 3 (R3) 12.06 11.60 11.91
    Resistance 2 (R2) 11.60 11.29 11.63 11.84
    Resistance 1 (R1) 11.25 11.10 11.02 11.31 11.78
    Pivot Point 10.79 10.79 10.68 10.82 10.79
    Support 1 (S1) 10.44 10.48 10.21 10.50 10.02
    Support 2 (S2) 9.98 10.29 10.01 9.96
    Support 3 (S3) 9.63 9.98 9.89
    Support 4 (S4) 9.69